Dulaglutide
Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial
Company n/r · Phase 3 · Completed · Enrollment 159
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| obese , non diabetic ,recieve dulaglutide | n/r | n/r | n/r | n/r | n/r |
| obese , non diabetic ,receive SEMAGLUTIDE | n/r | n/r | n/r | n/r | n/r |
| obese , non diabetic ,receive TIRAZEPETIDE | n/r | n/r | n/r | n/r | n/r |
| obese , diabetic ,recieve dulaglutide | n/r | n/r | n/r | n/r | n/r |
| obese , diabetic ,receive SEMAGLUTIDE | n/r | n/r | n/r | n/r | n/r |
| obese , diabetic ,receive TIRAZEPETIDE | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.